RUBIN PAUL D (CIK 1210905) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-03). Recent activity: Buy BIOA (5,437 shares), Buy BIOA (3,383 shares), Sell BIOA (8,820 shares), Buy BIOA (5,433 shares), Buy BIOA (2,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 5,437 | $22,346 |
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 3,383 | $22,226 |
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 8,820 | $157,084 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 5,433 | $22,330 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 2,000 | $13,140 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 7,433 | $150,890 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 5,433 | $22,330 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 2,000 | $13,140 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 7,433 | $139,369 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 5,433 | $22,330 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 2,000 | $13,140 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 7,433 | $95,514 |
| 2025-12-11 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 18,000 | $118,260 |
| 2025-12-11 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 18,000 | $216,000 |
| 2025-12-05 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Buy | 68,897 | $283,167 |
| 2025-12-05 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | Sell | 68,897 | $702,060 |
Source: SEC Form 4 filings · as of 2026-04-03